Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drucker

Showing results (61-70 of 549) with videos related to

Pageof 55
Sort By:
Mechanisms of Development|March 1, 1993
Murine FGF-4 gene expression is spatially restricted within embryonic skeletal muscle and other tissuesB J Drucker, M Goldfarb
Pediatric Diabetes|March 16, 2004
Synthesis, secretion and biological actions of the glucagon-like peptidesJ Lovshin, D J Drucker
Regulatory Peptides|June 1, 2000
New frontiers in the biology of GLP-2J Lovshin, D J Drucker
Public Health Reviews|January 1, 1993
Elimination of poliomyelitis in France: epidemiology and vaccine statusD J Malvy, J Drucker
The Journal of Biological Chemistry|March 4, 1994
Parathyroid hormone-related peptide is a downstream target for ras and src activationX Li, D J Drucker
Endocrinology|March 1, 1994
The LIM domain homeobox gene isl-1: conservation of human, hamster, and rat complementary deoxyribonucleic acid sequences and expression in cell types of nonneuroendocrine lineageM Wang, D J Drucker
Annual Review of Physiology|October 29, 2013
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2Daniel J Drucker, Bernardo Yusta
Nature Reviews. Endocrinology|December 12, 2022
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1Rola Hammoud, Daniel J Drucker
Lancet (London, England)|May 27, 2008
Intensive insulin therapy in newly diagnosed type 2 diabetesRavi Retnakaran, Daniel J Drucker
Molecular Endocrinology (Baltimore, Md.)|October 1, 1995
The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcriptionT Jin, D J Drucker
Pageof 55

Showing results (61-70 of 549) with videos related to

Sort By:
Pageof 55
Mechanisms of Development|March 1, 1993
Murine FGF-4 gene expression is spatially restricted within embryonic skeletal muscle and other tissuesB J Drucker, M Goldfarb
Pediatric Diabetes|March 16, 2004
Synthesis, secretion and biological actions of the glucagon-like peptidesJ Lovshin, D J Drucker
Regulatory Peptides|June 1, 2000
New frontiers in the biology of GLP-2J Lovshin, D J Drucker
Public Health Reviews|January 1, 1993
Elimination of poliomyelitis in France: epidemiology and vaccine statusD J Malvy, J Drucker
The Journal of Biological Chemistry|March 4, 1994
Parathyroid hormone-related peptide is a downstream target for ras and src activationX Li, D J Drucker
Endocrinology|March 1, 1994
The LIM domain homeobox gene isl-1: conservation of human, hamster, and rat complementary deoxyribonucleic acid sequences and expression in cell types of nonneuroendocrine lineageM Wang, D J Drucker
Annual Review of Physiology|October 29, 2013
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2Daniel J Drucker, Bernardo Yusta
Nature Reviews. Endocrinology|December 12, 2022
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1Rola Hammoud, Daniel J Drucker
Lancet (London, England)|May 27, 2008
Intensive insulin therapy in newly diagnosed type 2 diabetesRavi Retnakaran, Daniel J Drucker
Molecular Endocrinology (Baltimore, Md.)|October 1, 1995
The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcriptionT Jin, D J Drucker
Pageof 55